The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

Matthew Greenhawt, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David Khan, Cem Akin, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Moshe Ben-Shoshan, Jonathan Bernstein, Theresa Bingemann, Katharina Blumchen, Aideen Byrne, Antonio Bognanni, Dianne Campbell, Ronna Campbell, Zain Chagla, Edmond S. Chan, Jeffrey ChanPasquale Comberiati, Timothy E. Dribin, Anne K. Ellis, David M. Fleischer, Adam Fox, Pamela A. Frischmeyer-Guerrerio, Remi Gagnon, Mitchell H. Grayson, Caroline C. Horner, Jonathan Hourihane, Constance H. Katelaris, Harold Kim, John M. Kelso, David Lang, Dennis Ledford, Michael Levin, Jay Lieberman, Richard Loh, Doug Mack, Bruce MaZer, Giselle Mosnaim, Daniel Munblit, S. ShahZad Mustafa, Anil Nanda, John Oppenheimer, Kirsten P. Perrett, Allison Ramsey, Matthew Rank, Kara Robertson, Javed Sheikh, Jonathan M. Spergel, David Stukus, Mimi L. K. Tang, James M. Tracy, Paul J. Turner, Anna Whalen-Browne, Dana Wallace, Julie Wang, Susan Waserman, John K. Witry, Margitta Worm, Timothy K. Vander Leek, David B. K. Golden

Research output: Contribution to journalReview articlepeer-review

174 Citations (Scopus)
Original languageEnglish
Pages (from-to)3546-3567
JournalThe Journal of Allergy and Clinical Immunology: In Practice
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 2021

Keywords

  • SARS-CoV-2
  • COVID-19
  • Vaccination
  • Adenovirus-vector vaccine
  • mRNA vaccine
  • Anaphylaxis
  • Allergic reactions
  • Polyethylene glycol
  • Polysorbate 80
  • Skin testing
  • Shared decision making
  • GRADE
  • Allergy
  • Allergy specialist

Cite this